Altimmune

award trophy
Biotech

Altimmune GLP-1 curbs heavy drinking in ‘unequivocal’ ph. 2 win

Altimmune intends to next meet with the FDA to discuss the results and plan a potential path forward for pemvidutide in the indication.
Darren Incorvaia Jul 28, 2026 10:27am
next step ladder climb succeed win

Altimmune eyes phase 3 MASH trial as weight loss deepens

Dec 19, 2025 8:30am
parachute sun mountain sunrise

Yet another CDER leadership shake-up—Chutes & Ladders

Dec 5, 2025 8:30am
Parachute over a mountain in Switzerland

GSK chief steps down in stunning move—Chutes & Ladders

Oct 3, 2025 8:30am
Liver

Altimmune stock sinks on mixed ph. 2 MASH results for GLP-1 drug

Jun 26, 2025 8:41am
weigh scale goliath outweigh balance bigger smaller even

Altimmune touts 'best-in-class' lean mass data in weight loss

Jun 23, 2024 1:45pm